NCT05142111

Brief Summary

In this study patients with Multiple Sclerosis or Spinal Lesions will participate in two different types of treatments that aim to improve sexual and sentimental life. Behavioral (via questionnaires) and brain (via high-density electroencephalogram) effects associated with treatment will be studied.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2021

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

October 4, 2023

Status Verified

October 1, 2023

Enrollment Period

4 years

First QC Date

August 25, 2021

Last Update Submit

October 3, 2023

Conditions

Keywords

sexuality

Outcome Measures

Primary Outcomes (4)

  • Changes in quality of actual and perceived sexual health for females

    Assessed by means of a standardized questionnaire Female Sexual Dysfunction Questionnaire (Filocamo et al., 2014). 19 questions with 6 choices each. No maximum or minimum score defined. The experimenter evaluates the changes across sessions. This will be aggregated to other outcomes using factor analysis

    Before and after treatment (circa 6 weeks)

  • Changes in quality of actual and perceived sexual health for males

    Assessed by means of a standardized questionnaire MSHQ- (The Male Sexual Health Questionnaire). Questionnaire on male sexual health (Ugolini, \& Pescatori, 2005). 25 questions with 5 or 6 choices each. No maximum or minimum score defined. The experimenter evaluates the changes across sessions. This will be aggregated to other outcomes using factor analysis

    Before and after treatment (circa 6 weeks)

  • Changes in erectile function

    Assessed by means of a standardized questionnaire IIEF5- (International Index of Erectile Function). Questionnaire aimed at calculating the International Index of Erectile Function (Rosen et al., 1997). 5 questions with scores 1 to 5. Outcome range 5-25. Lower scores indicate poorer outcomes. This will be aggregated to other outcomes using factor analysis

    Before and after treatment (circa 6 weeks)

  • Changes in intimacy and sexuality

    Assessed by means of a standardized questionnaire MSISQ-15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire). Questionnaire on Intimacy and Sexuality in People with a Medullary Injury (Monti et al., 2020). 15 items with scores 1 to 5 each. Outcome range 15-75. Higher scores indicate poorer outcomes. This will be aggregated to other outcomes using factor analysis

    Before and after treatment (circa 6 weeks)

Secondary Outcomes (5)

  • Changes in brain spectral power after viewing neutral and erotic videos

    Before and after treatment (circa 6 weeks)

  • Changes in Mutual Information between brain regions after viewing neutral and erotic videos

    Before and after treatment (circa 6 weeks)

  • Psychological Well-Being

    Before and after treatment (circa 6 weeks)

  • Anxiety

    Before and after treatment (circa 6 weeks)

  • Changes in the assessment of the emotional response after viewing neutral and erotic videos

    Before and after treatment (circa 6 weeks)

Study Arms (2)

Sexual therapy

EXPERIMENTAL

In the sessions a series of questions will be proposed to the subject, who will be free to answer or not, being able to express questions in turn. The sessions will last about 45 minutes, and will be held once a week, for a total of 6 sessions.

Behavioral: Therapy

Mindfulness

ACTIVE COMPARATOR

During the mindfulness treatment the subjects will be subjected to sessions in which they will be invited to relax, to become aware of the present moment, of their body, through exercises that involve breathing, attention, and visualization of the body. The sessions will last about 45 minutes, and will be held once a week, for a total of 6 sessions.

Behavioral: Therapy

Interventions

TherapyBEHAVIORAL

Discussion with therapist

MindfulnessSexual therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • medical diagnosis of MS or spinal injury.
  • ability to sign informed consent.

You may not qualify if:

  • other relevant previous neurological or psychiatric pathologies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Camillo

Venice, 30126, Italy

RECRUITING

Related Publications (3)

  • Chandler BJ, Brown S. Sex and relationship dysfunction in neurological disability. J Neurol Neurosurg Psychiatry. 1998 Dec;65(6):877-80. doi: 10.1136/jnnp.65.6.877.

    PMID: 9854964BACKGROUND
  • Maffei A, Angrilli A. E-MOVIE - Experimental MOVies for Induction of Emotions in neuroscience: An innovative film database with normative data and sex differences. PLoS One. 2019 Oct 3;14(10):e0223124. doi: 10.1371/journal.pone.0223124. eCollection 2019.

    PMID: 31581254BACKGROUND
  • McCabe MP. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction. J Sex Marital Ther. 2001 May-Jun;27(3):259-71. doi: 10.1080/009262301750257119.

    PMID: 11354931BACKGROUND

MeSH Terms

Conditions

Multiple SclerosisSpinal Cord InjuriesSexuality

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and InjuriesSexual BehaviorBehavior

Study Officials

  • Daniele Marinazzo, PhD

    Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific collaborator

Study Record Dates

First Submitted

August 25, 2021

First Posted

December 2, 2021

Study Start

April 1, 2021

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

October 4, 2023

Record last verified: 2023-10

Locations